CMS says the 18-month demonstration will expand access to select weight-loss drugs while the agency gathers data on uptake, outcomes and program operations.

NeuroX, a neurology-focused online consultation service, and its physician network ATP Partners announced it will participate in the Centers for Medicare and Medicaid Services (CMS) GUIDE Program to ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...

JACKSON, Wyo.--(BUSINESS WIRE)--Remo Health, a virtual dementia care provider for patients and their family caregivers, is proud to announce its acceptance into the Centers for Medicare and Medicaid ...

Millions of people with Medicare are now eligible to get discounted GLP-1 drugs for weight loss under a special program. Here's how it will work.

Through partnerships with Tembo Health and AVVACare, Papa will connect people living with dementia and their families to trusted, nationally available in-home support and respiteMIAMI, June 25, 2026 ...

The University of Utah Aging Brain Care Clinic is participating in GUIDE. GUIDE is a model introduced by the Centers for Medicare and Medicaid Services (CMS) to promote improved dementia care.

If you are caring for a loved one with Alzheimer’s disease or another form of dementia, you already know how overwhelming the journey can be. Between doctor visits, medications, daily routines, and ...